Dr. Adele Amine, DO
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- Kentucky School of Medicine (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 111
Licensed in Texas since 2024, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: Kentucky School of Medicine
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
TX license V4086 (first issued 2024; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- Houston Methodist West Hospital Houston, TX
- St Michael Medical Center Silverdale, WA
- Bronson Battle Creek Hospital Battle Creek, MI
- Oaklawn Hospital Marshall, MI
Medical groups
- Remote Telehealth Services Texas, PLLC (10 clinicians)
- Amer Al-Karadsheh, M.d., P.a (9 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 111
- Services billed
- 1,780
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| New patient office or other outpatient visit, 30-44 minutes | 44 | 44 |
| Established patient office or other outpatient visit, 30-39 minutes | 42 | 37 |
| Insertion of needle into vein for collection of blood sample | 25 | 22 |
| Established patient office or other outpatient visit, 20-29 minutes | 22 | 22 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 20 | 14 |
| New patient office or other outpatient visit, 45-59 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Houston, TX | 127 |
| Metformin Hcl Other prescribers in Houston, TX | 46 |
| Jardiance (empagliflozin) Other prescribers in Houston, TX | 45 |
| Methimazole Other prescribers in Houston, TX | 44 |
| Alendronate Sodium Other prescribers in Houston, TX | 43 |
| Ozempic (semaglutide) Other prescribers in Houston, TX | 43 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Houston, TX | 42 |
| Humalog Kwikpen U-100 (insulin lispro) Other prescribers in Houston, TX | 32 |
| Trulicity (dulaglutide) Other prescribers in Houston, TX | 30 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Houston, TX | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 8 payments worth $294 in total to this clinician.
| Insulet Corporation | $127 |
|---|---|
| Madrigal Pharmaceuticals | $59.37 |
| Bayer HealthCare Pharmaceuticals Inc. | $23.39 |
| Corcept Therapeutics | $23.10 |
| Cequr Corporation | $21.04 |
| Novartis Pharmaceuticals Corporation | $20.53 |
| Ascensia Diabetes Care US Inc. | $19.05 |
| Food and Beverage | $294 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.